Explore expert-vetted resources on diseases of mind and sight.
Cognito Therapeutics CEO Brent Vaughan spoke about the pivotal HOPE Study, which uses an investigational medical device consisting of headphones and eyewear to deliver sensory stimulation treatment in the comfort of people’s homes.
Dr. Paul Aisen answers your top questions on Kisunla, a new Alzheimer's drug.
Explore the importance of understanding your genetic risk for Alzheimer’s and related dementias.
Learn from leading scientists about two research opportunities that do NOT involve taking medications.
Are AI programs the next frontier in forecasting, understanding, and managing Alzheimer’s?
Learn how early-onset Alzheimer’s is recognized, diagnosed, and treated and what separates it from the most common form of the disease
